{{Distinguish|Cimaterol}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 451180085
| IUPAC_name = 3-<nowiki/>{(''R'')-Dimethylamino-[(1''R'',2''R'')-2-hydroxycyclohexyl]}methyl]phenol
| image = Ciramadol.svg

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_status =
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 63269-31-8
| ATC_prefix = none
| ATC_suffix =
| PubChem = 44463
| ChEMBL = 2104132
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 40461
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9NQ109OW0G
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03523

<!--Chemical data-->
| C=15 | H=23 | N=1 | O=2 
| molecular_weight = 249.349 g/mol
| smiles = OC1=CC=CC([C@@H]([C@H]2CCCC[C@H]2O)N(C)C)=C1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H23NO2/c1-16(2)15(11-6-5-7-12(17)10-11)13-8-3-4-9-14(13)18/h5-7,10,13-15,17-18H,3-4,8-9H2,1-2H3/t13-,14+,15-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UVTLONZTPXCUPU-ZNMIVQPWSA-N
| synonyms = Ciramadol, WY-15705
}}

'''Ciramadol''' ('''WY-15,705''') is an [[opioid]] [[analgesic]] that was developed in the late 1970s<ref>US Patent 3928626 - Benzylamine Analgesics</ref> and is related to [[phencyclidine]], [[tramadol]], [[tapentadol]] and [[venlafaxine]].<ref>Cochrane AD, Bell R, Sullivan JR, Shaw J. Ciramadol. A new analgesic. ''Medical Journal of Australia''. 1979 Nov 3;2(9):501-2.</ref> It is a mixed [[agonist]]-[[antagonist]] for the [[mu-opioid receptor|Î¼-opioid receptor]] with relatively low abuse potential<ref>Preston KL, Bigelow GE, Liebson IA. Comparative evaluation of [[morphine]], [[pentazocine]] and ciramadol in postaddicts. ''Journal of Pharmacology and Experimental Therapeutics''. 1987 Mar;240(3):900-10.</ref> and a ceiling on [[respiratory depression]]<ref>Romagnoli A, Keats AS. Low ceiling respiratory depression by ciramadol. ''International Journal of Clinical Pharmacology Research''. 1986;6(6):451-5.</ref> which makes it a relatively safe drug. It has a slightly higher potency and effectiveness as an [[analgesic]] than [[codeine]],<ref>Downing JW, Brock-Utne JG, Holloway AM. Ciramadol - a new synthetic analgesic. A double-blind comparison with oral codeine for postoperative pain relief. ''South African Medical Journal''. 1983 Dec 10;64(25):978-82.</ref> but is weaker than [[morphine]].<ref>Powell WF. A double-blind comparison of multiple intramuscular doses of ciramadol, morphine, and [[placebo]] for the treatment of postoperative pain. ''Anesthesia and Analgesia''. 1985 Nov;64(11):1101-7.</ref>  Other side effects include [[sedation]] and [[nausea]] but these are generally less severe than with other similar drugs.<ref>Stambaugh JE Jr, McAdams J. Comparison of the analgesic efficacy and safety oral ciramadol, codeine, and placebo in patients with chronic cancer pain. ''Journal of Clinical Pharmacology''. 1987 Feb;27(2):162-6.</ref> 

== See also ==
{{colbegin|2}}
* [[Bromadol]]
* [[C-8813]]
* [[Faxeladol]]
* [[Profadol]]
* [[Tapentadol]]
* [[Tramadol]]
{{colend}}

== References ==
{{Reflist|2}}

{{Analgesics}}
{{Opioidergics}}

[[Category:Synthetic opioids]]
[[Category:Mu-opioid agonists]]
[[Category:Phenols]]
[[Category:Alcohols]]
[[Category:Amines]]


{{analgesic-stub}}